Skip to content

Clinical trials

Completed Multiple Sclerosis, Chronic Progressive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Chronic Progressive Status: Completed Country / region: United States Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20071
20092
20102
20112
20124
20135
20144
20154
20162
20172
20185
20193
20201
20212
20225
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johns Hopkins University5
Novartis Pharmaceuticals4
National Institute of Allergy and Infectious Diseases (NIAID)3
Novartis3
State University of New York at Buffalo3
Hoffmann-La Roche2
Opexa Therapeutics, Inc.2
VA Office of Research and Development2
AbbVie1
Biogen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Chronic Progressive51
Multiple Sclerosis25
Multiple Sclerosis, Relapsing-Remitting16
Autoimmune Diseases2
Demyelinating Diseases2
Disease Progression2
Fatigue2
Nerve Degeneration2
Autoimmune Diseases of the Nervous System1
Immune System Diseases1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.